Patient Navigation for Diabetic Retinopathy

Yale School of Medicine, New Haven, CT
Diabetic Retinopathy+1 More ConditionsPatient Navigation - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial is testing a patient navigator intervention to help people with diabetes who are at high risk of diabetic blindness. They want to see if it's feasible and acceptable before doing a bigger clinical trial.

Eligible Conditions
  • Diabetic Retinopathy

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: 18 months

18 months
Number of participant who had baseline eye exam
Repeat eye exam 18 months post enrollment
up to 18 month
Number of participants who completed a follow-up eye exam 12+ months after baseline eye exam

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

Intervention arm
1 of 1

Experimental Treatment

60 Total Participants · 1 Treatment Group

Primary Treatment: Patient Navigation · No Placebo Group · N/A

Intervention arm
Experimental Group · 1 Intervention: Patient Navigation · Intervention Types: Behavioral
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Navigation
Completed Phase 2

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 18 months

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,727 Previous Clinical Trials
20,519,532 Total Patients Enrolled
Kristen Nwanyanwu, MD, MHSPrincipal InvestigatorYale School of Medicine

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
New York100.0%
What site did they apply to?
Yale School of Medicine100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%
Why did patients apply to this trial?
  • "I want to cure or slow my retinopathy."
How many prior treatments have patients received?

How responsive is this trial?

Average response time
  • < 2 Days
Most responsive sites:
  1. Yale School of Medicine: < 48 hours
Typically responds via

Frequently Asked Questions

How many participants are being enrolled in the clinical trial?

"Affirmative. Data hosted on attests that this medical experiment, initially published on July 25th 2022 is recruiting participants as of now. Approximately 60 individuals are set to be enrolled in the trial at its lone site." - Anonymous Online Contributor

Unverified Answer

Has this research been opened up to new participants yet?

"That is correct. According to the information readily available on, this research project posted in late July 2022 and was recently updated at the beginning of September 2022 seeks 60 participants from a single medical centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.